2014 Volume 16 Issue 4 Published: 28 August 2014
  

  • Select all
    |

    论著

  • 论著
    Zhu Man;Wang Dongxiao;Guo Daihong;Huang Chunyan;Wang Yuqin;Yang Liping;Pei Fei;Wang Weilan;Tang Zhihui;Chen Chao;Ren Zhao
    2014, 16(4): 193-5.
    Abstract ( ) PDF ( )
    ObjectiveTo investigate the application of vancomycin in elderly inpatients.Methods
    The clinical data of elderly inpatients (≥60 years) treated with vancomycin from September 2012 to November 2013 in 5 hospitals including Peking University First Hospital, Beijing Hospital, Beijing Chao-Yang Hospital, Xuanwu Hospital of Capital Medical University, and Chinese PLA General Hospital were collected. All patients were divided into normal renal function group and renal insufficiency group. The application (dosage regimen, drug utilization situation, and therapeutic drug monitoring) and clinical efficacy of vancomycin and its effects on renal function in elderly patients were retrospectively analyzed. Drug utilization index (DUI) reflected the drug utilization situation. And parameters of renal function included serum creatinine (Scr), blood urea nitrogen (BUN) and creatinine clearance rate (Ccr).ResultsA total of 149 patients were enrolled in this study comprising 60 males and 89 females with age of 60-92(76±7) years. There were 87 cases in the normal renal function group and 62 cases in renal insufficiency group. The most widely used regimen of application of vancomycin was 0.50 g once every 12 hours in the normal renal function group (29/87, 33.33%) and 0.50 g once daily in the renal insufficiency group(30/62, 48.39%). The total dosage and time of using vancomycin were respectively 2 135.15 g and 1 919.5 d. And the DUI was 0.56. Among the 149 patients, 111 cases(74.50%) underwent blood concentration monitoring and there were no statistically significant differences in constituent ratio of undergoing blood concentration monitoring between the normal renal function group and the renal insufficiency group[70.11%(61/87) vs.80.65%(50/62),χ2=2.11,P=0.15]. In all patients undergoing blood concentration monitoring, trough concentration was detected and in 7 patients peak concentration was detected. The number of cases whose trough concentrations <10 mg/L was 30(49.18%) and 25 cases (50.00%) in the normal renal function group and the renal insufficiency group, respectively, and there were no statistically significant differences (χ2=2.16,P=0.54). The differences between before and after administration of vancomycin in Scr[(117±79) μmol/L vs. (119±81)μmol/L], BUN[(10.5±5.7) mmol/L vs. (12.5±8.0) mmol/L], and Ccr[(69±37) ml/min vs. (67±36) ml/min] in all the 149 patients were not statistically significant(all P>0.05). The differences between before and after administration of vancomycin in Scr[(59±16)μmol vs. (70±30)μmol/L, (189±110)μmol/L vs.(203±113)μmol/L], BUN[(7.4±3.5) mmol/L vs.(9.2±5.8) mmol/L, (14.8±6.5) mmol/L vs.(17.4±9.0) mmol/L], and Ccr[(107±29) ml/min vs.(96±26) ml/min, (44±30) ml/min vs.(33±16) ml/min] in the normal renal function group and the renal insufficiency group were not statistically significant (all P>0.05).ConclusionsThe use of vancomycin in elderly inpatients was relatively cautious. Dosage regimen should be adjusted timely according to the results of blood concentration and renal function tests and individualized administration should be adopted in order that the efficacy and safety could be improved.
  • 论著
    Liu Jiaming;Yan Suying;Liu Chen;Liu Ning;Li Xiaoling;Bai Xiangrong;Wang Yawei;Li Xingwei;Cheng Hongqin;Tang Jing;Chu Yanqi;Wang Yuqin
    2014, 16(4): 198-7.
    Abstract ( ) PDF ( )
    ObjectiveTo investigate the feasibility of detecting adverse drug event (ADE) using Global Trigger Tool (GTT) in Chinese medical institutions.MethodsDischarged patients′ records of the Xuanwu Hospital of Capital Medical University from January 1st to December 31st 2013 were collected. After sorting by discharged date, 30 cases were selected in a half month period by a random sampling tool of Microsoft Excel 2007 software. Unqualified cases were eliminated according to the inclusion criteria (patients aged 18 and over, one time admission in 2013, and hospitalization for more than 1 day) and exclusion criteria (patients in the Department of Obstetrics, Family Planning, Rehabilitation, Oncology, Pediatrics, and day-care ward). The 20 cases were reviewed every half a month in sequence of random sampling using 35 triggers, including laboratory indexes, antidotes, clinical symptoms, and treatment measures, that were identified by GTT recommendation, relevant foreign researches, and self-experience of Xuanwu Hospital of Capital Medical University. All cases were enrolled if the number of cases which met the inclusion criteria was less than 20. The cases in whom triggers could be detected were marked as the cases with positive triggers. The cases with positive triggers-related situations were further reviewed in order to identify or exclude ADE and then the identified ADEs were classified. The positive triggers and ADEs were analyzed by Microsoft Excel 2007 software and the positive predictive values of positive triggers were calculated.ResultsTotally 465 cases were reviewed. Of them, 256 were male and 209 female with the mean age of 57 (19~92) years. The time of hospital stay was 2 to 37 days with the mean hospital stay of 10 days. Of the 465 patients, in 208 patients(44.7%)positive triggers could be detected. Of all the 35 triggers, 22 triggers (62.9%) were positive referring to 342 times. There were 18 ADEs identified involving 16 patients and the detectable rate was 3.4% (16/465). Of the 18 ADEs, 13 ADEs had their corresponding triggers containing 8 triggers. The overall positive predictive value of 22 positive triggers was 3.8%. The 18 ADEs included pneumonia (2 ADEs), liver injury (2 ADEs), chill (2 ADEs), skin rash (2 ADEs), antibiotic-associated diarrhea (1 ADE), headache (1 ADE), dizziness (1 ADE), nausea and vomiting (1 ADE), hypoglycemia (1 ADE), over-sedation (1 ADE), delirium (1 ADE), bleeding (1 ADE), leucopenia (1 ADE), and excitation (1 ADE). There were 14 ADEs of class E and 4 ADEs of class F in the 18 ADEs which referred to 21 drugs including 5 kinds of antibacterial agents, 3 kinds of blood system drugs, 3 kinds of psychotherapeutic agents, 2 kinds of cardiovascular drugs, 2 kinds of hormone drugs, 2 kinds of Chinese patent medicines, 1 kind of lipid drug, 1 kind of drug acting bone metabolism, 1 kind of antipyretic analgesic, and 1 kind of anesthetic.ConclusionsGTT could help to early detect the signals of ADEs and provide the reference evidence of preventing drug risk. It is valuable that GTT is popularized and used in Chinese medical institutions.
  • 论著
    Li Wenjing;Huang Nan;Zhu Rongfei
    2014, 16(4): 205-4.
    Abstract ( ) PDF ( )
    ObjectiveTo understand the clinical characteristics of psychiatric adverse effects (PAE) caused by montelukast sodium and provide reference for clinical rational drug use.MethodsThe children who received montelukast sodium treatment in the department of allergy in Tongji Hospital from 2010 to 2013 were followed up and their data were collected. The diagnosis, situation of drug combination, the clinical manifestations, time of onset, and severity of the PAE, and the time to symptoms disappearing after drug discontinuation were analyzed.ResultsThe data of 1 481 children who met inclusion criteria were collected. Of them, 1 015 children were male and 466 were female. Their ages ranged from 3 to 17 years. Of the 1 481 patients, 623 children′s ages were 3-6 years, 603 were 7-12 years, and 255 were 13-17 years. Among them, 780 cases were diagnosed as allergic asthma and 701 cases allergic rhinitis. A total of 17 children developed PAE after treatment with montelukast sodium and the incidence rate was 1.15%(17/1 481). The incidence rate of PAE in male sodium and female children was 1.28(13/1 015) and 0.86%(4/466), respectively. The incidence rate of PAE among 3-6 year-old children, 7-12 year-old children,and 13-17 year-old children were 1.61% (10/623), 0.83% (5/603), and 0.78%(2/255), respectively. The incidence rate of PAE in children with allergic asthma and allergic rhinitis were 1.15% (9/780) and 114% (8/701), respectively. There were no significant differences in the incidence rates of PAE among different gender, ages, and diseases (all P> 0.05). Among the 17 children who developed PAE, 9 children developed sleep disorders (7 nightmare and 2 insomnia), 5 children developed behavior disorders (4 aggressiveness, 1 hyperactivity), 2 children developed unspecified anxiety, and 1 developed nightmares combined with hyperactivity. The PAE were mild in 14 patients and moderate in 3 patients. There were 15 patients whose PAE occurred within 1 week after montelukast sodium treatment and 1 patient whose PAE occurred within 2 week and 3 months. All the 17 patients recovered within 1 week after montelukast sodium discontinuation.ConclusionsThe PAE occurred in children after montelukast sodium treatment is mainly sleep disorders, especially nightmare. Most of PAE are mild and the children recover soon after drug withdrawal.
  • 论著
    Sun Junan;Xia Zongling;Luo Can
    2014, 16(4): 209-4.
    Abstract ( ) PDF ( )
    ObjectiveTo explore the role of CRUSADE score for evaluating the risk of gastrointestinal bleeding due to antiplatelet agents.MethodsThe hospitalized patients with coronary heart disease and received antiplatelet therapy for more than 1 year before hospitalization in department of internal medicine in the Third People′s Hospital of Cixi, Zhejiang Province from September 2010 to September 2013 were enrolled into the study. The patients were divided into the gastrointestinal bleeding group and the non-gastrointestinal bleeding group according to whether gastrointestinal bleeding occurred due to antiplatelet agents. The CRUSADE score was evaluated in the 2 groups and the relationship between the CRUSADE score and gastrointestinal bleeding was analyzed.ResultsA total of 787 patients with coronary heart disease who received antiplatelet therapy more than 1 year were collected. Forty patients with gastrointestinal bleeding were enrolled into the gastrointestinal bleeding group. One hundred and sixty patients were enrolled into the non-gastrointestinal bleeding group by equidistant sampling method randomly. The gastrointestinal bleeding group comprised 31 male and 9 female with age from 45 to 88 (71±9) years. The non-gastrointestinal bleeding group comprised 100 male and 60 female with age from 36 to 89 (65±13) years. There was statistically significant difference in age between the 2 groups (P<0.05). The percentage of cases of receiving aspirin enteric-coated tablets, clopidogrel hydrogen sulfate tablets, and both the above-mentioned drugs in the gastrointestinal bleeding group and the non-gastrointestinal bleeding group were 55%(22/40),10%(4/40),35%(14/40) and 54%(86/160),7%(11/160), 39%(63/160), respectively. The difference was not statistically significant (P>0.05). The percentage of cases who had history of gastroin-testinal bleeding and peptic ulcer in the gastrointestinal bleeding group and the non-gastrointestinal bleeding group were 30.0%(12/40) and 11.9%(19/160), respectively. The difference was statistically significant (P<0.05). There were 27.5%(11/40) and 27.5%(11/40) cases with the results of CRUSADE score at high risk and very high risk in the gastrointestinal bleeding group, 8.1%(13/160) and 10.6%(17/160) cases in the non-gastrointestinal bleeding group, respectively. The difference was statistically significant (P<0.05) .ConclusionsCRUSADE score can help to evaluate the risk of gastrointestinal bleeding in patients with coronary heart disease who received antiplatelet therapy. It is suggested that the patients with coronary heart disease as well as the CRUSADE score of high risk and very high risk should receive the combination of antiplatelet agents and the proton pump inhibitor, in order to prevent or reduce the gastroin-testinal bleeding.
  • 论著
    Wang Rui;Ren Zebin;Li Guofu
    2014, 16(4): 213-6.
    Abstract ( ) PDF ( )
    ObjectiveTo evaluate the efficacy and safety of dexmedetomidine in treatment of elderly patients in perioperative period.MethodsCNKI, CBM, VIP,WanFang Database, PubMed, Embase, Web of Science, and Cochrane Library from the inception to October 2013 were searched using "dexmedetomidine", "α2 receptor agonist", "elderly patients", "aged", "adverse reactions", "adverse drug reactions", "adverse events", and "safety" as key words. Randomized controlled trials (RCT) on dexmedetomidine treatment for elderly patients in perioperative period were collected and studies in accordance with inclusion criteria were analyzed with RevMan 5.2 software. The differences of heart rates during and after the operation, mean arterial pressure (MAP), the cumulative amount of fentanyl, and incidence of adverse reactions (vomiting, hypotension, bradycardia) between the dexmedetomidine group and the saline group were compared and the results were showed with weight mean difference (WMD), (relative risk,RR), and 95% confidence interval (CI).ResultsA total of 6 RCT papers involving 403 elderly patients (200 patients in the dexmedetomidine group and 203 patients in the saline group) were entered into this study. Of them, 4 RCT papers were high quality articles and 2 were low quality articles according to the Jadad scores. The heart rates and MAP in patients in the dexmedetomidine group were markedly lower than those in the saline group[heart rate: WMD =-11.70,95% CI (-13.76 to -9.65),P<0.01; MAP: WMD=-8.74, 95% CI (-10.81 to -6.68), P<0.01], the cumulative amount of fentanyl in patients in the dexmedetomidine group was markedly lower than that in the saline group [RR=-7.22,95%CI: -11.30 to -3.14, P<0.01]. There were no statistically significant differences in incidence of vomiting [RR=-0.11, 95% CI (-0.26 to -0.03)], bradycardia [RR=5.16,95% CI: 0.63 to 42.24], and hypotension [RR=1.01,95% CI: 0.28 to 3.69]in perioperative period between the two groups(all P>0.05).ConclusionDexmedetomidine could stabilize the heart rate and arterial pressure in elderly patients in perioperative period and have definite sedative effect and good drug safety.
  • 论著
    Zheng Jiao;Ning Ning;Yang Lijun
    2014, 16(4): 219-5.
    Abstract ( ) PDF ( )
    ObjectiveTo investigate the effect of puerarin on cytochrome P450 (CYP) 2D6 activity and its relationship with CYP2D6 genotypes in human.Methods(1)In vitro experiment: human liver microsomal incubation mixtures was prepared with normal liver tissues from a surgical excision of patients with introhepatic cholelithiasis; different concentrations of puerarin (0, 0.025, 0.050, 0.100, 0.200, 0.400, and 0.800 mmol/L) and metoprolol were added into the incubation mixtures and the productive rate of metoprolol metabolite (α-hydroxymetoprolol ) was detected using HPLC, which was used to access the activity of CYP2D6. (2)In vivo test: 18 male healthy volunteers with age of 19-26(22±4) years and weight of 62~75(69±7) kg were selected as the subjects. Of them, 6 patients were genotype of CYP450 2D6 *1/*1, 6 were genotype of *1/*10, and 6 were genotype of *10/*10. The test comprised 3 stages and was carried out using a two-phase crossover design. The subjects were divided into 2 groups by simple randomization method. The first stage (the 1st day to the 11th day): the subjects in one group received an IV infusion of puerarin 400 mg once daily for 10 days and the subjects in another group received nothing. All subjects received metoprolol 100 mg orally early in the morning on the 11th day. The second stage (the 12th to the 17th day): all subjects received nothing. The third stage (the 18th to the 28th day): the subjects, who received nothing in the first stage, received an IV infusion of puerarin 400 mg once daily for 10 days and the subjects in another group received nothing. All subjects received metoprolol 100 mg orally early in the morning on the 28th day. Urine was collected from 0 to 8 h after metoprolol administration on the 11th and 28th days. The concentration of metoprolol and α-hydroxymetoprolol was detected by HPLC and its ratio was used to assess CYP2D6 activity.ResultsThe results of in vitro experiment showed that α-hydroxymetoprolol levels in human liver microsomal incubation mixtures after treatment with puerarin 0, 0.025, 0.050, 0.100, 0.200, 0.400, and 0.800 mmol/L were (0.018±0.001), (0.015±0.001), (0.015±0.001), (0.012±0.001), (0.011±0.001), (0.010±0.001), and (0.005±0.002) mmol/(mg·h), respectively. The productive rate of α-hydroxymetoprolol decreased with increase of puerarin concentrations and the difference in population mean was statistically significant (F=30.750, P=0.000). The results of pairwise comparision showed that the productive rate of α-hydroxymetoprolol in the puerarin 0.100, 0.200, 0.400, and 0.800 mmol/L groups were markedly lower than those in the puerarin 0, 0.025, 0.050, 0.100, 0.200, 0.400, and 0.800 mmol/L groups (P<0.05); the productive rate of α-hydroxymetoprolol in the puerarin 0.200, 0.400, and 0.800 mmol/L groups were markedly lower than those in the puerarin 0.025 and 0.050 mmol/L groups (P<0.05); the productive rate of α-hydroxymetoprolol in the puerarin 0.800 mmol/L group was markedly lower than those in the puerarin 0.100, 0.200, and 0.400 mmol/L groups (P<005). The results of in vivo test showed that the ratios of metoprolol and α-hydroxymetoprolol in urine in the 18 subjects before and after puerarin treatment were 1.11±0.55 and 1.73±0.94, respectively. The difference was statistically significant (P<0.01). The changes of CYP2D6 activity in urine in all subjects with different CYP2D6 genotypes in the 3 groups were compared and the differences were not statistically significant.ConclusionPuerarin could inhibit the activity of CYP2D6 in a dose-dependent manner, but it is not related to the CYP2D6 genotypes.
  • 论著
    Zhao Hua;Rao Rong
    2014, 16(4): 224-3.
    Abstract ( ) PDF ( )
    ObjectiveTo analyze characteristics of drug resistance of Escherichia coli and Klebsiella pneumoniae to provide a basis of clinical rational drug use.MethodsData concerning samples collected from all the clinical departments in computer system of Department of Laboratory Medicine in Fangxian People′s Hospital of Hubei Province from January 2010 to December 2012 were browsed manually. Data of samples from which Escherichia coli and Klebsiella pneumoniae could be isolated were selected. Source of bacterial strains, clinical divisions, bacterial strains producing extended spectrum β-lactamase (ESBL), and drug sensitive test were documented.ResultsThere were 359 bacterial strains of Escherichia coli mainly from urine [121 strains (33.7%)] and 296 bacterial strains of Klebsiella pneumonia mainly from phlegm [165 strains (55.7%)]. Escherichia coli was mainly distributed in intensive care unit [88 strains (24.5%)], general surgery department [69 strains (19.2%)], and neurosurgery [56 strains (15.6%)] while Klebsiella pneumonia was mainly distributed in intensive care unit [69 strains (23.3%)], respiratory medicine [50 strains (16.9%)], and neurosurgery [36 strains (12.2%)]. Of the 359 bacterial strains of Escherichia coli, ESBL could be detected in 175 strains with a detectable rate of 48.7%; of the 296 bacterial strains of Klebsiella pneumonia, ESBL could be detected in 116 strains with a detectable rate of 39.2%. Imipenem, meropenem, cefotetan, and piperacillin/tazobactam showed low drug resistance to ESBL-producing strains. The drug resistance rates of ESBL-producing Escherichia coli were respectively 2.3%, 3.4%, 5.1%, and 8.6% to the above four antibacterial agents and those of Klebsiella pneumonia were 2.6%, 3.4%, 2.2%, and 2.8%, respectively.ConclusionEscherichia coli and Klebsiella pneumonia have high resistance to multiple antibacterial agents and the antibacterial agents should be chosen according to drug sensitivity test and results of ESBL testing.
  • 论著
    Zhang Wenhui;Yilihamu·Kelimuaji;Nusulaiti·Aihemaiti;Du Yunnan;Ma Xiaojie
    2014, 16(4): 227-5.
    Abstract ( ) PDF ( )
    ObjectiveTo investigate the effects of glucose and lipid metabolism disorder induced by olanzapine on cognitive function in rats.MethodsForty healthy male SD rats of clean degree were divided into the olanzapine group and the control group using random-digital table, each group comprised 20 rats. The rats in the olanzapine group received intragastric administration of olanzapine 1.2 mg/kg once daily for 4 weeks for duplicating adiposity model. The rats in the control group received intragastric administration of same volume of 0.9% sodium chloride solution once daily for 4 weeks. The rats′ body weight in the 2 groups were measured every week during the intragastric administration. The levels of serum fasting blood-glucose, total cholesterol (TC), triacylglycerol (TG), high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) in rats in the 2 groups were measured after the intragastric administration. The Y maze test was carried on and the number of shocks which was the criterion of learning ability were recorded and compared between the 2 groups. The Morris water maze was carried on and the escape latency was recorded and compared between the 2 groups. The morphological changes in hippocampal CA1 area in the 2 groups were observed after the maze experiments.ResultsThe body weight on the second, third, and fourth weeks of intragastric administration in the olanzapine group was higher than those in the control group (all P<0.05). The body weight on the fourth week of intragastric administration in the olanzapine group was 20% more than that in the control group (P<0.05). The levels of serum fasting glucose, TC, TG, and LDL-C in the olanzapine group were obviously higher than those in the control group, the level of serum HDL-C was significantly lower than that in the control group ( all P<0.05 ) at the end of the four weeks of intragastric administration. The result of Y maze test showed the number of shocks in the olanzapine group was obviously more than that in the control group [(82.65±0.12) times vs. (50.25±0.02) times,P<0.05]. The result of Morris water maze test showed the escape latency in the olanzapine group was longer than that in the control group [(62.20±0.10) s vs. (23.54±0.12)s, P<0.05] . The morphological experiment showed the malalignment, deletion, and edema appeared in the hippocampal CA1 area neurons in the olanzapine group at the end of four weeks of intragastric administration.ConclusionOlanzapine can increase the levels of rats′ blood-glucose and blood lipid, and affect the cognitive function.
  • 综述

  • 综述
    He Bishan;Lin Zichao;Huang Hongbing;Liu Tao;Wang Fenghua
    2014, 16(4): 232-5.
    Abstract ( ) PDF ( )
    Chemotherapeutic regimens based on fluoropyrimidines such as 5-fluorouracil, capecitabine, and tegafur, gimeracil and oteracil potassium (S1) are widely used in a variety of solid tumor therapy. Cancer patients are high-risk persons of thrombosis and anticoagulant therapy is recommended for patients with thrombosis or with risk factors of thrombosis. At present, warfarin is the widely used oral anticoagulant. There are drug interactions when 5-fluorouracil, capecitabine, and S1 are given in combination with warfarin and it may lead to elevated international normalized ratio and symptoms of bleeding. Most patients could recover after warfarin withdrawal, dosage reducing, and replacement with low-molecular heparin. However, a few patients may require blood transfusion. The mechanism of drug interactions due to concomitant use of fluoropyrimidines and warfarin remains unclear and may be related to inhibiting activity of metabolic enzyme of warfarin—hepatic cytochrome P450 2C9 by 5-fluorouracil or its metabolites.
  • 综述
    Wang Wanqing;Miao Liyan
    2014, 16(4): 237-5.
    Abstract ( ) PDF ( )
    Irinotecan is a chemotherapeutic agent widely used in the treatment of gastrointestinal cancer and small cell lung cancer. The common adverse reactions of irinotecan are delayed onset diarrhea and neutropenia. These adverse reactions are associated with genetic factors and non-genetic factors. Genetic factors include genetic polymorphisms of various enzymes and transporters, such as carboxylesterase, liver uridine diphosphate glucuronosyltransferase 1A, and cytochrome P450 3A4. Non-genetic factors including age, smoking, and drug combination can also affect the susceptibility of irinotecan and metabolism of drugs. Providing an individualized treatment according to different genotypes can improve clinical response of irinotecan and decrease the incidence of adverse reactions.
  • 中毒救治

  • 中毒救治
    Wei Hongjiang;Cui Xiutao;Yu Gang
    2014, 16(4): 242-2.
    Abstract ( ) PDF ( )
    A 46-year-old male patient mistook fresh radix aconite kusnezoffii and radix aconiti powder about 5 g and, after 3 hours, he developed consciousness disorder and generalized convulsion. The electrocardiogram showed ventricular flutter with a heart rate of 220 beats/min. Electric defibrillation and an IV push of amiodarone were given immediately. But his heart rhythm did not return to normal. An IV push of amiodarone was given again. Meanwhile an IV push of lidocaine 100 mg and 25% magnesium sulfate 8 ml (2 g) were administered. The heart rhythm normalized. The electrocardiogram revealed frequent multifocal polymorphic ventricular premature contractions. A continuous intravenous infusion of amiodarone and lidocaine via pump was continued. Two minutes later, polymorphic ventricular tachycardia recurred and the heart rate was 180-190 beats/min. None of IV push of amiodarone and lidocaine and electroversion was effective. After the second intravenous push of magnesium sulfate 8 ml (2 g), ventricular tachycardia remained however his heart rate decreased to 160-170 beats/min. So the patient received the third intravenous push of magnesium sulfate 8 ml (2 g) and his heart rate was 140-150 beats/min. Ten minutes later, the forth intravenous push of magnesium sulfate 8 ml (2 g) was given and his heart rhythm normalized. Two hours later, the patient was treated with hemoperfusion. At the first one hour, he had polymorphic ventricular tachycardia four times and every intravenous push of magnesium sulfate 1-2 g was effective. Next day, the patient had no symptoms and the electrocardiogram showed sinus rhythm with a rate of 75 beats/min.
  • 病例报告

  • 病例报告
    Sun Hongyan;Cao Kai;Sun Min
    2014, 16(4): 244-2.
    Abstract ( ) PDF ( )
    A 61-year-old male patient with lumbar disc herniation received oral methocarbamol 0.5 g twice daily. On day 6 of treatment, the lumbago was alleviated and the patient stopped the drug without permissions. Six days later, he took the same dose of methocarbamol for worsened lumbago. On day 7 of treatment with methocarbamol again, the patient developed icteric skin, dark urine and anorexia. Six days later, the patient stopped the drug again due to apocleisis. Laboratory tests showed the following results: alanine aminotransferase (ALT) 2 369 U/L, aspartate aminotransferase (AST) 1 198 U/L, direct bilirubin (DBil) 87.1 μmol/L, indirect bilirubin (IBil) 75.4 μmol/L. Drug-induced liver injury was diagnosed. He received IV infusions of glutathione 1.8 g once daily and magnesium isoglycyrrhizinate 0.2 g once daily. Two days later, laboratory tests showed the following results: ALT 1 331 U/L, AST 503 U/L, DBil 73.9 μmol/L, IBil 68.9 μmol/L. Thirteen days later, repeat liver function tests showed the following levels: ALT 231 U/L, AST 72 U/L, DBil 34.5 μmol/L, IBil 45.0 μmol/L. His therapy was changed to oral glutathione 0.4 g thrice daily and diammonium glycyrrhizinate 0.15 g thrice daily. His jaundice subsided at follow up after one month, and liver function tests showed the following levels: ALT 19 U/L, AST 21 U/L, DBil 2.3 μmol/L, IBil 11.4 μmol/L.
  • 病例报告
    Li Zhenghan;Wu Donghong;Xu Binhua;Liu Jie;Wang Liping
    2014, 16(4): 245-3.
    Abstract ( ) PDF ( )
    A 35-year-old female patient received oral thiamazole 10 mg twice daily, vitamin B4 20 mg thrice daily, and two tablets of batilol tablets (50 mg per tablet) thrice daily for hyperthyroidism. On week 2 of medication, because of decreasing level of white blood cells, thiamazole was reduced to 10 mg once daily and four tablets of berbamine hydrochloride tablets thrice daily were added to the regimen. On day 16 of medication, the patient experienced fever with a peak temperature of 37.8 ℃ and red rash and itching on the limbs followed by generalized arthralgia. On day 20, slight swelling and positive tenderness appeared on proximal interphalangeal joints of index fingers and middle fingers of both hands, and metacarpopha-langeal joints of right index finger and middle finger. Positive tenderness also appeared on her both wrist joints, both ankle joints, and bilateral knee joints. Laboratory tests revealed the following values: erythrocyte sedimentation rate 42 mm/1 h, C-reactive protein 32 mg/L, antinuclear antibodies(ANA) 1 ∶ 320, and anti-histone antibodies(AHA)(+). Thiamazole was stopped while the other drugs were continued as before. Subsequently, the symptoms of pain and swelling of her joints gradually improved. After half a year of drug withdrawal, the ANA and AHA became negative.
  • 病例报告
    Guo Haiping;Zhou Wenyan;Cui Shuping;Li Sa;Tong Qiuyan
    2014, 16(4): 247-1.
    Abstract ( ) PDF ( )
    A 59-year-old male patient received regularly aspirin, clopidogrel, etc. by mouth after operation for coronary angiography, balloon dilatation, and coronary stent implanting. Two months later, the patient developed multiple and superficial oral ulcer on his tongue and oral mucosa. The patient stopped clopidogrel medication by himself and other drugs were continued. The oral ulcer alleviated gradually and disappeared one month later. The oral ulcer recurred when the patient received clopidogrel for 2 months again and healed after the clopidogrel withdrawal.
  • 病例报告
    Wang Xinming;Wang Lei
    2014, 16(4): 249-2.
    Abstract ( ) PDF ( )
    A 3-year-old boy received an IV infusion of clindamycin 0.15 g twice daily for ulcerative stomatitis. Before giving clindamycin, his platelet count was 250×109/L. On day 2, the boy presented with red ecchymosis on left knee joint. On day 3, the boy developed gingival bleeding and skin scattered petechiae, his platelet count was 0 and activated partial thromboplastin time was 32 s. Clindamycin was stopped. IV infusions of methylprednisolone (30 mg, once daily) and human immunoglobulin (6 g, once daily), oral amino-polypeptide (0.2 g, thrice daily) were given. On day 4, his platelet count was 64×109/L, activated partial thromboplastin time was 26 s, prothrombin time was 12 s. After a week, the platelet count returned to 135×109/L and ecchymosis disappeared.
  • 病例报告
    Zhang Jing;Wang Ting;Guo Xiaofang;Qiao Jianfeng
    2014, 16(4): 249-2.
    Abstract ( ) PDF ( )
    A 78-year-old female patient with myocardial infarction received oral aspirin 100 mg once daily and clopidogrel hydrogen sulfate 75 mg once daily. She developed pruritus and erythema on her abdomen and both lower extremities in the next morning. The clopidogrel hydrogen sulfate was discontinued and she was treated with loratadine 10 mg once daily. Her pruritus had improved and erythema had subsided after 2 hours. On day 2, the patient self-administered clopidogrel hydrogen sulfate 75 mg. She presented with anaphylactoid symptoms again and loratadine was continued. Four days later, the patient underwent coronary angiography and percutaneous coronary intervention. She received dual antiplatelet therapy with oral ticagrelor 90 mg twice daily and aspirin 100 mg once daily after surgery. The patient had no discomfort at 6 months follow-up.
  • 病例报告
    Tang Rui;Zhang Hongyu
    2014, 16(4): 250-2.
    Abstract ( ) PDF ( )
    A 17-year-old female who was diagnosed as typeⅠhereditary angioedema (HAE-Ⅰ) received an IV infusion of 6-aminocaproic acid 4 g once daily. Headache and nausea appeared about one hour after the IV infusion and developed severe bitemporal headache accompanied with weakness, mental fatigue and difficult to move. The symptoms were disappeared about one hour after the IV infusion finished. The above-mentioned symptoms were recurrent and ingravescent during the IV infusion of 6-aminocaproic acid from the second to the eighth days. The symptoms were disappeared about one hour after the IV infusion finished.
  • 病例报告
    Li Ling;Song An;Song Guangyao
    2014, 16(4): 252-2.
    Abstract ( ) PDF ( )
    A 74-year-old male patient with coronary atherosclerotic heart disease given clopidogrel hydrogen sulfate, aspirin, Tongxinluo(通心络), coenzyme Q10, atorvastatin calcium, vitamin E and vitamin C after undergoing coronary artery stent implantation. He stopped taking atorvastatin calcium because of the lipid-lowering effect was not good and switched to rosuvastatin calcium 10 mg once daily by himself. The patient′s blood glucose level elevated within four months. His fasting blood glucose ranged from 6.5 to 7.8 mmol/L and postprandial blood glucose ranged from 7.7 to 10.5 mmol/L. Seven months later, his fasting blood glucose peaked at 12.5 mmol/L, and postprandial blood glucose peaked at 16.0 mmol/L, glycosylated hemoglobin level was 9.6%. He discontinued rosuvastatin calcium by himself. Three months later, the fasting blood glucose and postprandial blood glucose were down to 5.9 mmol/L and 7.4 mmol/L, glycosylated hemoglobin level was back to 6.6%.